What Role Will India Play In The Global COVID-19 Vaccine Narrative?
By Gunjan Bagla
While most Americans are focused on the incredible success of the COVID-19 vaccines developed and produced by Pfizer and Moderna under the $24 billion Operation Warp Speed, there is under-reported news from India that bears a closer look. The country plans to vaccinate its billion plus population using a combination of vaccines manufactured locally and its government donated millions of doses across 10 countries in parallel with a national domestic rollout. Indian companies will soon sign deals to sell their COVID vaccines globally.
High Volume Rollout
Serum Institute of India, in Pune, just began shipping the adenovirus-based Oxford-AstraZeneca